MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis,.
MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ Boston Scientific Corporation has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module when it is used to visualize and track the.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE™ Pulsed.
The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment.
/PRNewswire/ Wolters Kluwer s ftwilliam.com, the market s leading provider of content and solutions for retirement plan service providers, is announcing its.